Neurocrine Biosciences, Inc.
Free In-Depth Equity Research Report
Neurocrine Biosciences shares spiked 3.45 percent to close at $14.98 a share Wednesday. The stock traded between $14.80 and $15.33 on volume of 1.20 million shares traded. Analysts at have recently upgraded the company’s rating to “outperform” from “market perform”. Shares of Neurocrine Biosciences have gained approximately 100.0 percent year-to-date. Going forward ... (see research report)